Study guide

12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

AACN CCRN Adult

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Strategy

1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy

2 Cardiovascular I — Hemodynamics & Shock

2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology

3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias

3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS

4 Respiratory I -- Failure, ABGs & Acute Conditions

4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma

5 Respiratory II — Mechanical Ventilation

5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications

6 Endocrine Emergencies

6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises

7 Renal & Genitourinary

7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy

8 Gastrointestinal

8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition

9 Hematology, Immunology & Integumentary

9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries

10 Neurological I — Stroke, TBI & ICP

10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring

11 Neurological II & Musculoskeletal

11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal

12 Behavioral & Psychosocial

12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

13 Multisystem I — Sepsis & MODS

13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response

14 Multisystem II — Trauma, Burns & Toxicology

14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies

15 Synergy Model, Advocacy & Caring

15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices

16 Collaboration, Systems Thinking & Diversity

16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning

17 Clinical Inquiry, Ethics & End-of-Life

17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care

12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

Key Takeaways Explain This Topic AI

Delirium tremens appear 48-96 hours after the last drink with clouded sensorium and severe autonomic instability; untreated mortality is 5-15%.

Benzodiazepines are first-line for alcohol withdrawal, dosed by CIWA-Ar (treat at >=8-10, >15 is severe); beta-blockers and clonidine mask symptoms but do not prevent seizures or DTs.

Give thiamine BEFORE glucose in alcohol-dependent patients to prevent Wernicke encephalopathy.

Verbal de-escalation is first-line for agitation; restraints are a last resort, require a provider order (never PRN), and violent-restraint use needs a face-to-face evaluation within 1 hour.

Naloxone reverses opioid overdose; benzodiazepines are first-line for cocaine/stimulant agitation and cardiovascular effects.

Last updated: July 2026

Alcohol Withdrawal — Timeline, Assessment, and Treatment

Alcohol is the most common substance-withdrawal emergency in the ICU, and untreated delirium tremens (DTs) still carry up to 5-15% mortality . Withdrawal reflects the loss of alcohol's GABA-enhancing, glutamate-suppressing effect, producing central-nervous-system and autonomic hyperexcitability. Symptoms follow a fairly predictable clock from the last drink.

  • Time since last drink Stage Key features
  • 6-12 h Minor withdrawal Tremor, anxiety, insomnia, nausea, mild tachycardia/hypertension, diaphoresis

12-24 h Alcoholic hallucinosis Visual/tactile/auditory hallucinations with an INTACT sensorium; near-normal vitals

24-48 h Withdrawal seizures Generalized tonic-clonic, usually brief and self-limited

48-96 h (up to 10 d) Delirium tremens (DTs) Disorientation, severe autonomic instability, fever, agitation, hallucinations

Distinguish alcoholic hallucinosis (12-24 h; hallucinations with a clear sensorium and stable vitals) from DTs (48-96 h; clouded sensorium/disorientation , severe autonomic storm, fever). Withdrawal seizures are typically generalized and early (24-48 h); focal seizures or status epilepticus point to another cause.

CIWA-Ar and Symptom-Triggered Dosing

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) scores 10 items — nausea, tremor, sweats, anxiety, agitation, tactile/auditory/visual disturbances, headache, and orientation — for a maximum of 67 . Interpretation: <8-10 minimal, 8-15 moderate, and >15 severe with high seizure/DT risk. Symptom-triggered dosing — giving a benzodiazepine only when the CIWA-Ar crosses a threshold (commonly 8-10) — uses less total drug and shortens treatment versus fixed-schedule dosing, and is preferred whenever the patient can be reliably scored. CIWA-Ar is invalid in the intubated or unassessable patient; use a RASS-based protocol there.

Pharmacologic Management

Benzodiazepines are first-line because of GABA cross-tolerance — lorazepam, diazepam, or chlordiazepoxide . Long-acting agents (diazepam, chlordiazepoxide) give a smoother self-taper, but lorazepam is preferred in hepatic dysfunction or the elderly because it has no active metabolites. Refractory DTs may need phenobarbital or adjunctive propofol (with intubation) plus escalating benzodiazepine doses. Give thiamine before any glucose to prevent Wernicke encephalopathy, and replace folate, magnesium, potassium, and phosphate . Beta-blockers and alpha-2 agonists (clonidine, dexmedetomidine) blunt autonomic symptoms such as tachycardia and hypertension, but they do not correct the GABA deficit and do not prevent seizures or DTs — used alone they can dangerously mask escalating withdrawal.

Opioid and Stimulant Emergencies

Opioid overdose presents with the triad of respiratory depression, pinpoint (miotic) pupils, and depressed consciousness; after supporting ventilation, give naloxone , titrating to restore adequate respirations rather than full alertness so as to avoid precipitated withdrawal. Opioid withdrawal , graded with the COWS scale, is intensely uncomfortable but rarely life-threatening in adults; manage with methadone or buprenorphine and adjuncts such as clonidine.

Stimulant (cocaine, methamphetamine) intoxication produces agitation, hypertension, tachycardia, hyperthermia, seizures, and chest pain from coronary vasospasm (with myocardial infarction or aortic dissection risk). Benzodiazepines are first-line for agitation and cardiovascular symptoms because they reduce sympathetic drive. Classic teaching is to avoid beta-blockers alone in acute cocaine toxicity because of theoretical unopposed alpha-mediated vasoconstriction. Also distinguish toxidromes with hyperthermia and altered mentation: serotonin syndrome (serotonergic agents; clonus, hyperreflexia, rapid onset) versus neuroleptic malignant syndrome (antipsychotics; lead-pipe rigidity, hyporeflexia, slower onset) — both require stopping the offending drug and aggressive cooling.

  • Psychiatric Emergencies
  • Suicidal Ideation

Screen directly — asking about suicide does not increase risk . A patient with active ideation, a plan, or intent requires continuous 1:1 observation , a ligature- and means-safe environment (remove cords, sharps, belts, and unsecured medications), immediate provider notification, and psychiatric consultation. Document the risk assessment and every intervention. Never leave the patient alone or rely on a bed alarm alone.

Agitation and De-escalation

For the agitated or potentially violent patient, verbal de-escalation is first-line : approach calmly, keep a safe distance and a clear exit, use a low steady voice, set firm limits, and offer realistic choices. If de-escalation fails and there is imminent danger, escalate to pharmacologic management (a benzodiazepine such as lorazepam, with or without an antipsychotic such as haloperidol), reserving physical restraint for last resort .

Patient Safety — Restraints and Falls

Restraints are a least-restrictive, last-resort intervention used only after less-restrictive measures fail and the patient poses imminent harm (behavioral/violent) or would disrupt life-sustaining therapy such as an endotracheal tube (non-violent/medical-surgical).

Restraint type Order / evaluation Time limits

Violent / self-destructive (behavioral) Provider order + face-to-face eval within 1 hour Adults <=4 h; ages 9-17 <=2 h; <9 y <=1 h; renew up to 24 h before new order

Non-violent / non-self-destructive (medical-surgical) Provider order to protect lines/tubes Renewed per hospital policy (often up to 24 h)

Key CMS and Joint Commission rules the CCRN tests: a restraint requires a provider order — never a standing PRN order ; for violent/self-destructive restraint a face-to-face evaluation within 1 hour is mandatory, and monitoring includes circulation, skin integrity, range of motion, toileting, hydration, and nutrition, with frequent reassessment (often every 15 minutes for behavioral restraint). Secure ties with quick-release knots to the bed frame, never the side rail , and remember restraints themselves carry harm — asphyxiation, aspiration, nerve/circulatory injury, pressure injury, venous thromboembolism, and worsened agitation and delirium — so discontinue at the earliest safe moment. Fall prevention uses a validated risk tool ( Morse Fall Scale or Hendrich II ), bed/chair alarms, low beds, nonslip footwear, uncluttered rooms, call-light access, scheduled toileting, and medication review (sedatives, opioids, and benzodiazepines raise risk). Because delirium and immobility drive both falls and further delirium, early mobility and delirium prevention are core safety strategies, not competing ones.